본문으로 건너뛰기
← 뒤로

Exploring the potential of artificial intelligence in assessing the risk of gastric neoplastic lesions in patients with corpus atrophic gastritis.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2026 Vol.29(1) p. 159-168

Dilaghi E, Cesaroni E, Ligato I, Silvestri M, Liuzzi G, Annibale B, Lucidi S, Esposito G, Sciandrone M

📝 환자 설명용 한 줄

[BACKGROUND] Corpus atrophic gastritis (CAG) requires endoscopic-histological surveillance due to the risk of developing gastric neoplastic lesions (GNL).

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Dilaghi E, Cesaroni E, et al. (2026). Exploring the potential of artificial intelligence in assessing the risk of gastric neoplastic lesions in patients with corpus atrophic gastritis.. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 29(1), 159-168. https://doi.org/10.1007/s10120-025-01679-7
MLA Dilaghi E, et al.. "Exploring the potential of artificial intelligence in assessing the risk of gastric neoplastic lesions in patients with corpus atrophic gastritis.." Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 29, no. 1, 2026, pp. 159-168.
PMID 41123822

Abstract

[BACKGROUND] Corpus atrophic gastritis (CAG) requires endoscopic-histological surveillance due to the risk of developing gastric neoplastic lesions (GNL). This study aimed to identify variables associated with GNL development at long-term follow-up using a Fisher score-based feature-ranking-approach coupled with a One-Class Support-Vector-Machine (SVM) model.

[METHODS] A dataset containing 30 clinical, endoscopic, and histological variables from consecutive CAG patients (2001-2023) adhering to a surveillance-program was considered. GNL presence at the longest available follow-up was recorded. Gastric biopsies and histological evaluations followed the updated-Sydney-system. A Fisher score-based feature ranking method and a One-Class SVM were employed to select key variables linked to GNL development, and then validated with synthetically generated data.

[RESULTS] Overall, 355 CAG patients were initially considered. Of these, 36 were excluded due to the presence of GNL at baseline gastroscopy, and 216 for missing data. Thus, a total of 103 patients were considered and grouped into: CAG patients with [22 patients (F 68.1%), median-age 68(35-83) years] and without GNL at follow-up [81 patients (F 72.8%) median-age 59(26-84) years]. After a median follow-up of 60(12-192) months, 13 epithelial GNL (gastric adenocarcinoma or high/low-grade dysplasia) and nine type-1 gastric-neuroendocrine-tumors (T1gNET) were recorded. Parietal-cell-antibodies and pepsinogen-I < 30 μg/l were associated with epithelial GNL and T1gNET. Antral inflammation and age > 60 were linked to epithelial GNL, while anti-thyroperoxidase-antibodies, smoking, and dyspeptic-symptoms were linked to T1gNET. Low-dose aspirin and H. pylori eradication therapy showed inverse associations with epithelial GNL and T1gNET, respectively.

[CONCLUSIONS] This is the first study in which an AI-model simultaneously considers clinical, endoscopic, and histological features from a dataset of CAG patients, showing the potential to identify variables associated with GNL development.

MeSH Terms

Humans; Stomach Neoplasms; Gastritis, Atrophic; Middle Aged; Male; Female; Aged; Adult; Aged, 80 and over; Artificial Intelligence; Follow-Up Studies; Risk Assessment; Gastroscopy; Precancerous Conditions; Risk Factors

같은 제1저자의 인용 많은 논문 (2)